Mirum Pharmaceuticals Inc (MIRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,363 | -87,942 | -163,415 | -135,665 | -83,988 |
| Depreciation Amortization | 25,983 | 25,290 | 11,946 | 3,238 | 595 |
| Income taxes - deferred | N/A | N/A | N/A | -6,580 | N/A |
| Accounts receivable | -48,055 | -11,426 | -43,974 | -20,727 | N/A |
| Other Working Capital | -19,715 | 22,591 | -19,221 | -21,050 | 16,983 |
| Other Operating Activity | 120,977 | 61,812 | 143,720 | 60,648 | -66,348 |
| Operating Cash Flow | $55,827 | $10,325 | $-70,944 | $-120,136 | $-132,758 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -23,000 | -69,132 | 125,671 | 7,978 | -40,429 |
| PPE Investments | -954 | -993 | -109 | -278 | -24 |
| Net Acquisitions | N/A | N/A | -212,762 | N/A | N/A |
| Purchase Sale Intangibles | N/A | -20,000 | -20,000 | N/A | -19,000 |
| Other Investing Activity | 0 | -20,000 | -20,000 | 0 | 89,000 |
| Investing Cash Flow | $-23,954 | $-90,125 | $-107,200 | $7,700 | $48,547 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 305,304 | N/A | N/A |
| Common Stock Issued | 40,142 | 17,699 | 227,154 | 114,639 | 9,012 |
| Other Financing Activity | 0 | 0 | -195,858 | -5,552 | 64,454 |
| Financing Cash Flow | $40,142 | $17,699 | $336,600 | $109,087 | $73,466 |
| Exchange Rate Effect | 3,222 | -1,297 | -133 | 12 | -1 |
| Beginning Cash Position | 222,928 | 286,326 | 128,003 | 131,340 | 142,086 |
| End Cash Position | 298,165 | 222,928 | 286,326 | 128,003 | 131,340 |
| Net Cash Flow | $75,237 | $-63,398 | $158,323 | $-3,337 | $-10,746 |
| Free Cash Flow | |||||
| Operating Cash Flow | 55,827 | 10,325 | -70,944 | -120,136 | -132,758 |
| Capital Expenditure | -954 | -993 | -109 | -278 | -24 |
| Free Cash Flow | 54,873 | 9,332 | -71,053 | -120,414 | -132,782 |